CAPORALI, ROBERTO FELICE
CAPORALI, ROBERTO FELICE
Dipartimento di Scienze Cliniche e di Comunità
Biologics or Janus Kinase Inhibitors in Rheumatoid Arthritis Patients Who are Insufficient Responders to Conventional Anti-Rheumatic Drugs
2024 E.G. Favalli, G. Maioli, R. Caporali
Retention rate of biologic and targeted synthetic anti-rheumatic drugs in elderly rheumatoid arthritis patients: data from GISEA registry
2024 A. Manfredi, M. Fornaro, C. Bazzani, S. Perniola, A. Cauli, A. Rai, E.G. Favalli, S. Bugatti, M. Rossini, R. Foti, F. Conti, G. Lopalco, A. Scalvini, C. Garufi, M. Congia, R. Gorla, E. Gremese, F. Atzeni, R. Caporali, F. Iannone, M. Sebastiani
Pre-Rheumatology Referral Consultation and Investigation Pattern in Children with Joint Complaints: Focus on Juvenile Idiopathic Arthritis
2024 A. Marino, P. Baldassarre, C. Ferrigno, A. Biuso, M. Minutoli, F. Baldo, S. Costi, M.V. Gattinara, R.F. Caporali, C.B. Chighizola
Pulmonary and extra-pulmonary effects of lung transplantation in an Italian cohort of patients with systemic sclerosis
2024 C. Iannone, M.R. Pellico, L.C. Morlacchi, V. Rossetti, M. Vicenzi, L. Beretta, A. Severino, P. Airò, F. Cacciapaglia, V. Codullo, P. Faggioli, A. Iagnocco, F. Meloni, L. Mercante, M. Saracco, S. Stano, E. Zaccara, A. Minniti, S. Cavalli, G. Trignani, F. Blasi, M. Nosotti, M. Boffini, R. Caporali, N. Del Papa
Investigating the role of Endothelial Dysfunction in Antiphospholipid Syndrome by using Patient-Specific Endothelial Colony-Forming Cells
2024 R. Ciceri, M. Bacci, A. Cancellara, F. Tumminello, M. Gerosa, A. Saresini, C. Iannone, L.M. Argolini, R.F. Caporali, C. Lodigiani, M.P. Donadini, S. Della Bella, F. Calcaterra, D. Mavilio
The management of patients with inflammatory bowel disease-associated spondyloarthritis: Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) and Italian Society of Rheumatology (SIR) recommendations based on a pseudo-Delphi consensus
2024 F.S. Macaluso, F. Caprioli, L. Benedan, C. Bezzio, R. Caporali, A. Cauli, M.S. Chimenti, F. Ciccia, S. D'Angelo, M.C. Fantini, S. Festa, F. Iannone, E. Lubrano, P. Mariani, C. Papi, G. Provenzano, D. Pugliese, A. Rispo, S. Saibeni, C. Salvarani, A. Variola, M. Zenga, A. Armuzzi, A. Orlando, R. Gerli
Difficult-to-treat psoriatic arthritis: refining the definition using a statistical model in a real-life cohort
2024 E.G. Favalli, G. Biganzoli, G. Cincinelli, M. Ferrito, E. Luconi, M. Manara, M. Biggioggero, P. Boracchi, R. Caporali
Belimumab-induced periungual pyogenic granulomas: A case report
2024 C.B. Chighizola, I. Suardi, A. Marino, M. Gattinara, S. Costi, A. Cattaneo, M. Gerosa, R. Caporali
CPPD disease presenting with acute arthritis of the first metatarsophalangeal joint
2024 M. Ferrito, S. Sirotti, P. SARZI PUTTINI, R. Caporali, G. Filippou
The heterogeneity of lung involvement in vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic syndrome: a case of hypersensitivity pneumonitis-like pattern
2024 C. Iannone, M.R. Pellico, C. Campochiaro, L. Tescaro, M. Zompatori, A. Caminati, S. Harari, R. Caporali
JAK inhibitors in the treatment of adult patients with juvenile idiopathic arthritis: a retrospective monocentric experience
2024 C.B. Chighizola, M.R. Pellico, M. Pandolfi, L. Marelli, M. Cornalba, I. Pontikaki, S. Costi, M. Gattinara, A. Marino, E. Miserocchi, R. Caporali
Identification of two autoantigens recognised by circulating autoantibodies as potential biomarkers for diagnosing giant cell arteritis
2024 E. Pesce, M. Bombaci, S. Croci, M. Bonacini, C. Marvisi, C. Ricordi, S. Monti, F. Muratore, S. Abrignani, R. Caporali, M.O. Borghi, C. Salvarani, P.M. Villiger, R. Grifantini, P.L. Meroni
Deciphering the clinical significance of longitudinal antiphospholipid antibody titers
2024 C.B. Chighizola, R. Willis, G. Maioli, S. Sciascia, L. Andreoli, O. Amengual, M. Radin, M. Gerosa, T. Atsumi, G. de Jesus, L. Trespidi, D.W. Branch, R. Caporali, D. Andrade, R. Roubey, M. Petri, M.L. Bertolaccini
Olive Oil and Nuts in Rheumatoid Arthritis Disease Activity
2023 R. De Vito, F. Fiori, M. Ferraroni, S. Cavalli, R. Caporali, F. Ingegnoli, M. Parpinel, V. Edefonti
Rheumatoid Arthritis from Easy to Complex Disease: From the “2022 GISEA International Symposium”
2023 S. Perniola, M.S. Chimenti, F.R. Spinelli, B. Frediani, R. Foti, S. Ferrigno, C. Garufi, G. Cassone, V. Venerito, F. Atzeni, R. Caporali, F. Conti, E.G. Favalli, F. Iannone, M. Sebastiani, G.F. Ferraccioli, G. Lapadula, E. Gremese
Disease activity and disease-related factors are drivers of patient global assessment in rheumatoid arthritis: a real-life cross-sectional study
2023 I. Suardi, C. Posio, E. Luconi, P. Boracchi, R. Caporali, F. Ingegnoli
Long-term use of burosumab for the treatment of tumor-induced osteomalacia
2023 C. Crotti, F. Zucchi, C. Alfieri, R. Caporali, M. Varenna
Tight control in patients with rheumatoid arthritis treated with targeted therapies across the COVID-19 pandemic era
2023 A.F. Luppino, G. Cincinelli, A. Orenti, P. Boracchi, E.G. Favalli, R. Caporali, F. Ingegnoli
Owning Pets Reduces the Perception of Disease Activity in Patients With Rheumatoid Arthritis
2023 C. Posio, I. Suardi, R. Caporali, F. Ingegnoli
The impact of EMA recommendations on the real-life use of Janus kinases inhibitors for rheumatoid arthritis: the Expanded Risk Score in RA as a tool to quantify the risk of cardiovascular events
2023 E.G. Favalli, G. Cincinelli, S. Germinario, R. Di Taranto, F. Orsini, G. Maioli, M. Biggioggero, M. Ferrito, R. Caporali